Companies
ByHeart
the finished-product offtaker layer — a breast-milk-science-based, end-to-end infant-formula brand that has raised 395 million US dollars (including 95 million in May 2024), built two domestic manufacturing facilities in Portland, Oregon and Allerton, Iowa,…
- Country
- United States
Clean Label Project Certified
FDA-registered facility
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $395 million total; $95 million in latest financing (May 13, 2024) | pulse2.com · prnewswire.com |
| Capacity | Sufficient to feed approximately 500,000 infants annually | pulse2.com · foodnavigator.com · prnewswire.com |
| Certification | Clean Label Project Certified (three-time) | pulse2.com · prnewswire.com |
| Regulatory approval | Reading, Pennsylvania facility is FDA-registered | foodnavigator.com · prnewswire.com |
| Production site | Reading, Pennsylvania; Portland, Oregon; Allerton, Iowa | byheart.com · prnewswire.com |
| Revenue | $380 million (as of 2024) medium confidence | privco.com |
Independent sources: foodnavigator.com · privco.com · prnewswire.com · pulse2.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Precision-fermented infant formula | food-alt-protein | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.